James Paul
7PUBLICATIONS
178CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jul 28, 2021
Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT.Olivia Wu, Elaine McCartney, Robert Heggie
|Jan 13, 2021
Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer.Timothy J Iveson, Alberto F Sobrero, Takayuki Yoshino
|Jan 09, 2020
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.Laura Fachal, Hugues Aschard, Jonathan Beesley
|Dec 20, 2019
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.Timothy Iveson, Kathleen A Boyd, Rachel S Kerr
|May 16, 2019
Association analyses identify 31 new risk loci for colorectal cancer susceptibility.Philip J Law, Maria Timofeeva, Ceres Fernandez-Rozadilla
|Dec 19, 2018
Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk.Yaohua Yang, Lang Wu, Xiang Shu
Pageof 2
Frequent Collaborators
3 joint publications
Andrea Harkin
2 joint publications
Xiao-Ou Shu
2 joint publications
Timothy J Iveson
2 joint publications
Paul D P Pharoah
2 joint publications
Joe Dennis
2 joint publications
Ian Tomlinson
2 joint publications
Douglas F Easton
2 joint publications
Kenneth Muir
2 joint publications
Alicja Wolk
2 joint publications
Heli Nevanlinna
